61 results
F-1/A
IINN
Inspira Technologies Oxy B.H.N. Ltd
20 May 24
Registration statement (foreign) (amended)
4:02pm
of our strategy to reach this goal, and in parallel to pursuing regulatory approvals, we are actively working to establish collaborations with strategic … more accessible to millions of patients worldwide. We expect for these activities to support our strategy plan to reach market penetration and adoption
F-1
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
of Mechanical Ventilation. As part of our strategy to reach this goal, and in parallel to pursuing regulatory approvals, we are actively working … , with the goal of making our solutions more accessible to millions of patients worldwide. We expect for these activities to support our strategy plan to reach
424B5
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Prospectus supplement for primary offering
4:01pm
Ventilation. As part of our strategy to reach this goal, and in parallel to pursuing regulatory approvals, we are actively working to establish … of making our solutions more accessible to millions of patients worldwide. We expect for these activities to support our strategy plan to reach market
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
systems. These advancements are part of its strategy to offer more patient-focused, data-informed care. The integration of these technologies signifies
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
25 Mar 24
Inspira™ Technologies Reports Full Year 2023 Financial Results
9:27am
authorities, with expectations for more agreements to follow.”
“From a business strategy perspective, we are currently focused on working with potential
6-K
EX-99.3
ejsmumv0hi
27 Feb 24
Report of Foreign Private Issuer
7:15am
6-K
EX-99.1
n6a9vamuvlf wv
8 Feb 24
Report of Foreign Private Issuer
9:15am
6-K
EX-99.1
qc2jzxfu47wi8kf
30 Jan 24
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
8:40am
6-K
EX-99.1
8ihf6x1 2d2h
9 Jan 24
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
9:00am
6-K
EX-99.1
1s4wwh6sefmqu 1sn
2 Jan 24
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
9:05am
424B5
fm9 8l0967
28 Dec 23
Prospectus supplement for primary offering
9:28am
6-K
EX-99.1
7bnpgxs3h64
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-99.1
s18 fai92
26 Dec 23
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
4:01pm
6-K
EX-99.1
utp6oa2
11 Dec 23
In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil to Medical Advisory Board
9:29am
6-K
EX-99.1
qbbal7sh
29 Nov 23
Report of Foreign Private Issuer
9:22am
6-K
EX-99.1
acezwbum
16 Nov 23
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
9:27am
POS AM
6sfl329ky9 l2n01
10 Oct 23
Prospectus update (post-effective amendment)
5:00pm
6-K
EX-99.2
l7t2snhwh3y v9iwjind
2 Oct 23
Interim Condensed Financial Statements
4:01pm
6-K
EX-99.1
uiysyxn9uhdgtyp6n4
9 Aug 23
Report of Foreign Private Issuer
8:38am